H5N1 News and Research

Latest H5N1 News and Research

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

CRO to run CEL-SCI's upcoming Phase III clinical trial

CRO to run CEL-SCI's upcoming Phase III clinical trial

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

NanoViricides announces filing of its quarterly report with the SEC

NanoViricides announces filing of its quarterly report with the SEC

Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data

Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data

WHO investigates cases of H1N1 drug resistance in U.S., Britain

WHO investigates cases of H1N1 drug resistance in U.S., Britain

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

New FluCide better than the older version

New FluCide better than the older version

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Inovio Biomedical announces positive test results of its consensus influenza vaccines

DxNA announces successfull evaluation of its GeneSTAT PCR system

DxNA announces successfull evaluation of its GeneSTAT PCR system

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

Why avian flu virus has not caused a pandemic?

Why avian flu virus has not caused a pandemic?

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Asuragen enters into an exclusive agreement with Life Technologies

Asuragen enters into an exclusive agreement with Life Technologies

New Web-based application for tracking the H1N1 flu virus across the globe

New Web-based application for tracking the H1N1 flu virus across the globe

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.